H-Index
38
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
call: +1.631.629.4327
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
MSMbanner

AmJCaseRep
MedSciTechnol

eISSN: 2329-0358

Urgent liver transplantation for nevirapine-induced acute liver failure: Report of a case and review of the literature

Juan Carlos Lopez-Delgado, Rafael Mañez Mendiluce, Teresa Serrano Pinol, Xose Pérez Fernández, Laura Sanchez, Rosa Granada Vicente

Ann Transplant 2012; 17(1): 122-127

DOI: 10.12659/AOT.882645

Available online:

Published: 2012-03-31


#882645

Background:    Acute liver failure (ALF) due to antiretroviral treatment is a rare but a fatal complication in HIV-infected patients. Non-nucleoside retroviral transcriptase inhibitors are known to cause hepatotoxicity and exceptionally acute hepatic failure.
    Case Report:    We report a case of nevirapine-induced acute liver failure successfully managed with orthotopic liver transplantation (OLT). Antiretroviral therapy including raltegravir, zidovudine and abacavir was reintroduced 6 days after transplantation. No interaction with immunosuppressive agents was observed and the patient had a complete recovery.
    Conclusions:    Urgent OLT should be considered in HIV patients with nevirapine-induced ALF because of the poor outcome despite intensive supportive conservative treatment. Concomitant use of highly active antiretroviral therapy (HAART) and immunosuppression could be feasible if treatment is performed cautiously.

Keywords: nevirapine hepatotoxicity, urgent liver transplantation , acute liver failure, antiretroviral drugs, Immunosuppressive Agents



Back